May 26, 2018
Rose
Dexcom started out the year strong following the FDA clearance of its integrated continuous glucose monitor the G6. In its Q1 earnings call, the company reported a 30 percent increase in revenue compared to Q1 of 2017, bringing its total revenue to $184 million. When the FDA gave Dexcom the nod for the G6 it became the first interoperable CGM to get the designation. According to the earnings call, the technology is set for a full launch by June.
from MobiHealthNews https://ift.tt/2INiQK3
May 26, 2018
Rose
MobiHealthNews
No comments
Related Posts:
UnitedHealthcare, Fitbit, and Castlight share secrets to workplace wellness success- Mixed reality, extrasensory, and other trends for healthcare VR
- HIMSS acquires Healthbox to get in the innovation consulting game
- UnitedHealthcare adds Apple Watch to Motion employee wellness program
- A realistic look at the hype of machine learning and AI
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment